{
  "abstract": "Cachexia is defined as a loss of more than 5% of body weight or a body mass index (BMI) of less than 20 kg/m² due to chronic disease.1 It involves decreased muscle strength, fatigue, anorexia, reduced fat-free mass and abnormal biomarkers like anaemia and hypoalbuminaemia.2 The exact mechanism is unclear, but it leads to significant changes in fat, carbohydrate and protein metabolism.",
  "authors": [
    {
      "affiliations": [
        "Department of Clinical Pharmacy, Hacettepe University Faculty of Pharmacy, Ankara, Ankara, Turkey"
      ],
      "name": "Emine Ecem Kilinc"
    },
    {
      "affiliations": [
        "Department of Clinical Pharmacy, Hacettepe University Faculty of Pharmacy, Ankara, Ankara, Turkey"
      ],
      "name": "Izgi Bayraktar"
    },
    {
      "affiliations": [
        "Department of Clinical Pharmacy, Hacettepe University Faculty of Pharmacy, Ankara, Ankara, Turkey"
      ],
      "name": "Emre Kara"
    },
    {
      "affiliations": [
        "Department of Clinical Pharmacy, Hacettepe University Faculty of Pharmacy, Ankara, Ankara, Turkey"
      ],
      "name": "Kutay Demirkan"
    },
    {
      "affiliations": [
        "Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Ankara, Turkey"
      ],
      "name": "Murat Akova"
    }
  ],
  "title": "Beyond conventional dosing: tailoring antimicrobial regimens for cachexia",
  "uid": "858151ab-7b61-5d50-8cfb-36f00566b5dd"
}